This NOSI intends to encourage small businesses to translate kidney precision medicine discoveries and technologies.
Recent gains in access to kidney tissue and bio-samples and advances in multi-scale interrogation of human tissue and single cells have set the stage for precision medicine to be applied to kidney disease. Specifically, several cohort studies have included kidney biopsies [e.g., the Kidney Precision Medicine Project (KPMP) and the Nephrotic Syndrome Study Network (NEPTUNE)], and research consortia have advanced novel tools and technologies to interrogate bio-samples and released multi-omic data to the public. These bio-samples, technology, and data offer opportunities for technology development and translational research in the area of kidney precision medicine.
This notice applies to due dates on or after January 5, 2021 and subsequent receipt dates through September 5, 2023.